These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 30439373)

  • 1. Neuroimaging of chronic MDMA ("ecstasy") effects: A meta-analysis.
    Müller F; Brändle R; Liechti ME; Borgwardt S
    Neurosci Biobehav Rev; 2019 Jan; 96():10-20. PubMed ID: 30439373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective.
    Thomasius R; Zapletalova P; Petersen K; Buchert R; Andresen B; Wartberg L; Nebeling B; Schmoldt A
    J Psychopharmacol; 2006 Mar; 20(2):211-25. PubMed ID: 16510479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users.
    Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; Ramsøy T; Jernigan TL; Knudsen GM
    Arch Gen Psychiatry; 2011 Jun; 68(6):562-76. PubMed ID: 21646575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging in moderate MDMA use: A systematic review.
    Mueller F; Lenz C; Steiner M; Dolder PC; Walter M; Lang UE; Liechti ME; Borgwardt S
    Neurosci Biobehav Rev; 2016 Mar; 62():21-34. PubMed ID: 26746590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroimaging research in human MDMA users: a review.
    Cowan RL
    Psychopharmacology (Berl); 2007 Jan; 189(4):539-56. PubMed ID: 16847678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative PET studies of the serotonin transporter in MDMA users and controls using [11C]McN5652 and [11C]DASB.
    McCann UD; Szabo Z; Seckin E; Rosenblatt P; Mathews WB; Ravert HT; Dannals RF; Ricaurte GA
    Neuropsychopharmacology; 2005 Sep; 30(9):1741-50. PubMed ID: 15841106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study.
    Kish SJ; Lerch J; Furukawa Y; Tong J; McCluskey T; Wilkins D; Houle S; Meyer J; Mundo E; Wilson AA; Rusjan PM; Saint-Cyr JA; Guttman M; Collins DL; Shapiro C; Warsh JJ; Boileau I
    Brain; 2010 Jun; 133(Pt 6):1779-97. PubMed ID: 20483717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress.
    Parrott AC
    J Psychopharmacol; 2006 Mar; 20(2):147-63. PubMed ID: 16510474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain serotonin transporter binding in former users of MDMA ('ecstasy').
    Selvaraj S; Hoshi R; Bhagwagar Z; Murthy NV; Hinz R; Cowen P; Curran HV; Grasby P
    Br J Psychiatry; 2009 Apr; 194(4):355-9. PubMed ID: 19336788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects.
    Reneman L; de Win MM; van den Brink W; Booij J; den Heeten GJ
    J Psychopharmacol; 2006 Mar; 20(2):164-75. PubMed ID: 16510475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are ecstasy induced serotonergic alterations overestimated for the majority of users?
    Szigeti B; Winstock AR; Erritzoe D; Maier LJ
    J Psychopharmacol; 2018 Jul; 32(7):741-748. PubMed ID: 29733742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral (1)H MRS alterations in recreational 3, 4-methylenedioxymethamphetamine (MDMA, "ecstasy") users.
    Chang L; Ernst T; Grob CS; Poland RE
    J Magn Reson Imaging; 1999 Oct; 10(4):521-6. PubMed ID: 10508318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram.
    Liechti ME; Baumann C; Gamma A; Vollenweider FX
    Neuropsychopharmacology; 2000 May; 22(5):513-21. PubMed ID: 10731626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
    Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
    Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview.
    Gouzoulis-Mayfrank E; Daumann J
    J Psychopharmacol; 2006 Mar; 20(2):188-93. PubMed ID: 16510477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin transporter availability, neurocognitive function and their correlation in abstinent 3,4-methylenedioxymethamphetamine users.
    van de Blaak FL; Dumont GJH
    Hum Psychopharmacol; 2022 Jan; 37(1):e2811. PubMed ID: 34506649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MDMA, serotonergic neurotoxicity, and the diverse functional deficits of recreational 'Ecstasy' users.
    Parrott AC
    Neurosci Biobehav Rev; 2013 Sep; 37(8):1466-84. PubMed ID: 23660456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
    de Win MM; Reneman L; Reitsma JB; den Heeten GJ; Booij J; van den Brink W
    Psychopharmacology (Berl); 2004 May; 173(3-4):376-82. PubMed ID: 14726997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A voxel-based PET investigation of the long-term effects of "Ecstasy" consumption on brain serotonin transporters.
    Buchert R; Thomasius R; Wilke F; Petersen K; Nebeling B; Obrocki J; Schulze O; Schmidt U; Clausen M
    Am J Psychiatry; 2004 Jul; 161(7):1181-9. PubMed ID: 15229049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of dose, sex, and long-term abstention from use on toxic effects of MDMA (ecstasy) on brain serotonin neurons.
    Reneman L; Booij J; de Bruin K; Reitsma JB; de Wolff FA; Gunning WB; den Heeten GJ; van den Brink W
    Lancet; 2001 Dec; 358(9296):1864-9. PubMed ID: 11741626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.